Medium

ZS

In

ZS Associates

by

ZS

·

3d ago

Why better supply chain visibility doesn’t lead to better decisions

Supply chain visibility shows what changed, not how to respond. Learn why decisions break down across and how decision orchestration helps.

Why better supply chain visibility doesn’t lead to better decisions

In

ZS Associates

by

ZS

·

Nov 3

Extended-stay pricing power is rising. Here’s how operators can capture it

Extended-stay demand is outpacing supply. Learn how operators can build the pricing capability to capture the 2027 pricing power window.

A photo of several skyscrapers taken from below.

In

ZS Associates

by

ZS

·

Oct 30

Bridging the planning-execution divide: AI’s next frontier in distribution and logistics

AI’s next frontier in distribution: an intelligence layer that connects supply chain planning to execution across the movement of goods.

A person walks through a dark, angular tunnel with glowing blue and orange light strips forming geometric shapes along the walls and ceiling.

ZS

·

Oct 28

Why AI agents in commercial pharma need a governed context layer

AI agents that look good in a demo often struggle against real-world commercial data. Ask the same question twice and you may get two…

Why AI agents in commercial pharma need a governed context layer

In

ZS Associates

by

ZS

·

Oct 26

The accumulation problem: Why metabolic dysfunction connects women’s health conditions

Why do women’s health conditions go undiagnosed for years? Explore the metabolic link and what life sciences companies can do about it.

An Asian woman with black hair against a blue background, looking at a phone. A streak of light blue light surrounds her.

In

ZS Associates

by

ZS

·

Oct 26

The missing layer in rare disease launches

Why direct-to-patient is becoming a core capability for rare disease launches, helping patients move from awareness to action.

A close-up of a dropper with liquid medicine with a colorful abstract background behind it.

In

ZS Associates

by

ZS

·

Oct 22

Rare disease’s competitive era has arrived

Competition is now the norm in rare disease. See what’s behind the shift and how biopharma companies can differentiate earlier.

Rare disease’s competitive era has arrived

In

ZS Associates

by

ZS

·

Oct 15

How Medicare Advantage plans can manage performance as one system

Learn how Medicare Advantage plans can connect performance levers, detect risks earlier and act before issues affect bids and margins.

How Medicare Advantage plans can manage performance as one system

In

ZS Associates

by

ZS

·

Oct 6

From vibe coding to value: Hardening agentic applications with the AI spine

Learn how an AI spine helps enterprises turn agentic AI prototypes into governed, production-ready applications that deliver scalable…

From vibe coding to value: Hardening agentic applications with the AI spine

In

ZS Associates

by

ZS

·

Sep 28

The economics of expertise: what AI means for the future of scientific talent

AI is reshaping scientific expertise in R&D. Leaders must preserve the experiences that build judgment as routine work becomes automated

The economics of expertise: what AI means for the future of scientific talent

ZS

ZS helps improve life and how we live it. We transform ideas into impact to help our partner companies deliver better outcomes for all.

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech